Omniome is a biotechnology company developing a proprietary DNA sequencing platform capable of delivering unsurpassed sequencing accuracy.
| Date | Funding Round | Funding Raised | Price per Share | IPO Valuation |
|---|---|---|---|---|
| 1/9/2020 | Series C | $511MM | $XXX.XX | $XXX.XX |
| 7/30/2018 | Series B-1 and B-2 | $233.69MM | $XXX.XX | $XXX.XX |
| 1/1/2016 | Series A-1 and A-2 | $75.5MM | $XXX.XX | $XXX.XX |
